tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Quanterix Hold Rating: Balancing Underperformance with Strategic Opportunities
PremiumRatingsQuanterix Hold Rating: Balancing Underperformance with Strategic Opportunities
2M ago
Quanterix Adopts New Bylaws Amid Financial Challenges
Premium
Company Announcements
Quanterix Adopts New Bylaws Amid Financial Challenges
2M ago
Quanterix Announces Cooperation Agreement with Kent Lake
Premium
Company Announcements
Quanterix Announces Cooperation Agreement with Kent Lake
2M ago
Quanterix downgraded to Hold from Buy at Nephron Research
PremiumThe FlyQuanterix downgraded to Hold from Buy at Nephron Research
3M ago
Quanterix Completes Acquisition of Akoya Biosciences
Premium
Company Announcements
Quanterix Completes Acquisition of Akoya Biosciences
3M ago
Quanterix Revises Deadlines for Stockholder Proposals
Premium
Company Announcements
Quanterix Revises Deadlines for Stockholder Proposals
3M ago
Quanterix director buys $506K in common stock
PremiumThe FlyQuanterix director buys $506K in common stock
4M ago
Akoya Biosciences price target lowered to $1.14 from $3 at Morgan Stanley
Premium
The Fly
Akoya Biosciences price target lowered to $1.14 from $3 at Morgan Stanley
4M ago
Hold Rating on Quanterix Amid Merger Uncertainties and Economic Pressures
Premium
Ratings
Hold Rating on Quanterix Amid Merger Uncertainties and Economic Pressures
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100